My guess its hard put an estimate on 'how much' because we appear to be in a new paradigm. the eye in a petri, 3D organiods, testing on the DNA of the actual clinical trial participants before the clinical trial and LEI's database of clinical trial participants all means its likely to be significantly more efficient / cost effective process than normal. how much more...who knows? how much saving is fast-tracking from phase1 to pivotal clinical trials in potentially 3 months worth? the CEO / Mgmt will have done their sums and I suspect the amount raised is exactly what they need - no more - no less. now for execution...
My guess its hard put an estimate on 'how much' because we...
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PYC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
13.0¢ |
Change
0.005(4.00%) |
Mkt cap ! $606.5M | |||
| Open | High | Low | Value | Volume |
| 12.5¢ | 13.0¢ | 12.0¢ | $415.6K | 3.255M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 112056 | 12.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 13.0¢ | 127118 | 2 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| PYC (ASX) Chart |